Zac1 is an essential transcription factor for cardiac morphogenesis

Circulation Research

Volumn 106, Issue 6, 2010, Pages 1083-1091

  Yuasa, Shinsuke ^a,b   Onizuka, Takeshi ^a,b   Shimoji, Kenichiro ^a,b   Ohno, Yohei ^a,b   Kageyama, Toshimi ^a,b   Yoon, Sung Han ^a,b   Egashira, Toru ^a,b   Seki, Tomohisa ^a,b   Hashimoto, Hisayuki ^a,b   Nishiyama, Takahiko ^a,b   Kaneda, Ruri ^a   Murata, Mitsushige ^a,b   Hattori, Fumiyuki ^a   Makino, Shinji ^a   Sano, Motoaki ^a   Ogawa, Satoshi ^b   Prall, Owen W J ^c,e   Harvey, Richard P ^c,d   Fukuda, Keiichi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Department of Internal Medicine   (China)

^c VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Heart development; Transcription factor; Zac1 Plagl1

Indexed keywords

ATRIAL NATRIURETIC FACTOR; DNA; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; LUCIFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ALPHA MHC; TRANSCRIPTION FACTOR BNP; TRANSCRIPTION FACTOR NKX2.5; TRANSCRIPTION FACTOR ZAC1; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; ZINC FINGER PROTEIN 5; ZINC FINGER PROTEIN 6;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA BINDING; EMBRYO; GENE EXPRESSION; GENE INACTIVATION; GENE MUTATION; GENETIC ANALYSIS; HEART ATRIUM SEPTUM DEFECT; HEART DEVELOPMENT; HEART VENTRICLE SEPTUM DEFECT; HEART VENTRICLE WALL; HETEROZYGOSITY; HOMOZYGOSITY; MALE; MORPHOGENESIS; MOUSE; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN ISOLATION; RAT;

ANIMALS; APOPTOSIS; ATRIAL NATRIURETIC FACTOR; BINDING SITES; CELL CYCLE PROTEINS; CERCOPITHECUS AETHIOPS; COS CELLS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE REGULATORY NETWORKS; GENES, TUMOR SUPPRESSOR; GENOMIC IMPRINTING; GESTATIONAL AGE; HEART; HEART DEFECTS, CONGENITAL; HOMEODOMAIN PROTEINS; MICE; MICE, INBRED C57BL; MICE, INBRED ICR; MICE, MUTANT STRAINS; MORPHOGENESIS; MUTATION; NATRIURETIC PEPTIDE, C-TYPE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEIN PRECURSORS; RATS; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

EID: 77950992264     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.109.214130     Document Type: Article

References (31)

1. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676.
2. Lin Q, Schwarz J, Bucana C, Olson EN. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science. 1997;276:1404-1407.
3. Arceci RJ, King AA, Simon MC, Orkin SH, Wilson DB. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol. 1993;13:2235-2246.
4. Li QY, Newbury-Ecob RA, Terrett JA, Wilson DI, Curtis AR, Yi CH, Gebuhr T, Bullen PJ, Robson SC, Strachan T, Bonnet D, Lyonnet S, Young ID, Raeburn JA, Buckler AJ, Law DJ, Brook JD. Holt-Oram syndrome is caused by mutations in TBX5, a member of the Brachyury (T) gene family. Nat Genet. 1997;15:21-29.
5. Lints TJ, Parsons LM, Hartley L, Lyons I, Harvey RP. Nkx-2.5: a novel murine homeobox gene expressed in early heart progenitor cells and their myogenic descendants. Development. 1993;119:419-431.
6. Olson EN. Gene regulatory networks in the evolution and development of the heart. Science. 2006;313:1922-1927.
7. Yuasa S, Itabashi Y, Koshimizu U, Tanaka T, Sugimura K, Kinoshita M, Hattori F, Fukami S, Shimazaki T, Ogawa S, Okano H, Fukuda K. Transient inhibition of BMP signaling by Noggin induces cardiomyocyte differentiation of mouse embryonic stem cells. Nat Biotechnol. 2005;23: 607-611.
8. Spengler D, Villalba M, Hoffmann A, Pantaloni C, Houssami S, Bockaert J, Journot L. Regulation of apoptosis and cell cycle arrest by Zac1, a novel zinc finger protein expressed in the pituitary gland and the brain. EMBO J. 1997;16:2814-2825.
9. Abdollahi A, Pisarcik D, Roberts D, Weinstein J, Cairns P, Hamilton TC. LOT1 (PLAGL1/ZAC1), the candidate tumor suppressor gene at chromosome 6q24-25, is epigenetically regulated in cancer. J Biol Chem. 2003;278:6041-6049.
10. Piras G, El Kharroubi A, Kozlov S, Escalante-Alcalde D, Hernandez L, Copeland NG, Gilbert DJ, Jenkins NA, Stewart CL. Zac1 (Lot1), a potential tumor suppressor gene, and the gene for epsilon-sarcoglycan are maternally imprinted genes: identification by a subtractive screen of novel uniparental fibroblast lines. Mol Cell Biol. 2000;20:3308-3315.
11. Sprenkle AB, Murray SF, Glembotski CC. Involvement of multiple cis elements in basal-and alpha-adrenergic agonist-inducible atrial natriuret-ic factor transcription. Roles for serum response elements and an SP-1-like element. Circ Res. 1995;77:1060-1069.
12. Varrault A, Gueydan C, Delalbre A, Bellmann A, Houssami S, Aknin C, Severac D, Chotard L, Kahli M, Le Digarcher A, Pavlidis P, Journot L. Zac1 regulates an imprinted gene network critically involved in the control of embryonic growth. Dev Cell. 2006;11:711-722.
13. Song K, Backs J, McAnally J, Qi X, Gerard RD, Richardson JA, Hill JA, Bassel-Duby R, Olson EN. The transcriptional coactivator CAMTA2 stimulates cardiac growth by opposing class II histone deacetylases. Cell. 2006;125:453-466.
14. Abdollahi A, Godwin AK, Miller PD, Getts LA, Schultz DC, Taguchi T, Testa JR, Hamilton TC. Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res. 1997;57:2029-2034.
15. Kas K, Voz ML, Roijer E, Astrom AK, Meyen E, Stenman G, Van de Ven WJ. Promoter swapping between the genes for a novel zinc finger protein and beta-catenin in pleiomorphic adenomas with t(3;8)(p21;q12) translocations. Nat Genet. 1997;15:170-174.
16. Landrette SF, Kuo Y-H, Hensen K, van Waalwijk van Doorn-Khosrovani SB, Perrat PN, Van de Ven WJM, Delwel R, Castilla LH. Plag1 and Plagl2 are oncogenes that induce acute myeloid leukemia in cooperation with Cbfb-MYH11. Blood. 2005;105:2900-2907.
17. Hensen K, Van Valckenborgh ICC, Kas K, Van de Ven WJM, Voz ML. The tumorigenic diversity of the three PLAG family members is associated with different DNA binding capacities. Cancer Res. 2002;62: 1510-1517.
18. DeChiara TM, Robertson EJ, Efstratiadis A. Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 1991;64:849-859.
19. Luedi PP, Hartemink AJ, Jirtle RL. Genome-wide prediction of imprinted murine genes. Genome Res. 2005;15:875-884.
20. Wilkins JF, Haig D. What good is genomic imprinting: the function of parent-specific gene expression. Nat Rev Genet. 2003;4:359-368.
21. Varmuza S, Mann M. Genomic imprinting-defusing the ovarian time bomb. Trends Genet. 1994;10:118-123.
22. Falls JG, Pulford DJ, Wylie AA, Jirtle RL. Genomic imprinting: implications for human disease. Am J Pathol. 1999;154:635-647.
23. Wilkinson LS, Davies W, Isles AR. Genomic imprinting effects on brain development and function. Nat Rev Neurosci. 2007;8:832-843.
24. Kamiya M, Judson H, Okazaki Y, Kusakabe M, Muramatsu M, Takada S, Takagi N, Arima T, Wake N, Kamimura K, Satomura K, Hermann R, Bonthron DT, Hayashizaki Y. The cell cycle control gene ZAC/PLAGL1 is imprinted-a strong candidate gene for transient neonatal diabetes. Hum Mol Genet. 2000;9:453-460.
25. Smith RJ, Arnaud P, Konfortova G, Dean WL, Beechey CV, Kelsey G. The mouse Zac1 locus: basis for imprinting and comparison with human ZAC. Gene. 2002;292:101-112.
26. Arima T, Kamikihara T, Hayashida T, Kato K, Inoue T, Shirayoshi Y, Oshimura M, Soejima H, Mukai T, Wake N. ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome. Nucl Acids Res. 2005;33: 2650-2660.
27. D'Addio AP, Moschini L, Sistopaoli F, Marinelli E, Vitarelli A.[Two cases of Beckwith-Wiedemann syndrome. Morphogenetic characteristics, cardiac involvement and current diagnostic possibilities]. Minerva Pediatr. 1994;46:509-515.
28. Greenwood RD, Somer A, Rosenthal A, Craenen J, Nadas AS. Cardiovascular abnormalities in the Beckwith-Wiedemann syndrome. Am J Dis Child. 1977;131:293-294.
29. Kapur S, Kuehl KS, Midgely FM, Chandra RS. Focal giant cell cardio-myopathy with Beckwith-Wiedemann syndrome. Pediatr Pathol. 1985; 3:261-269.
30. Kuehl KS, Kapur S, Toomey K, Varghese PJ, Midgley FM, Ruckman RN. Focal cardiomyopathy and ectopic atrial tachycardia in Beckwith syndrome. Am J Cardiol. 1985;55:1234-1235.
31. Shirani J, Natarajan K, Varga P, Vitullo DA. Discrete subvalvular aortic stenosis in the Beckwith-Wiedemann syndrome. Pediatr Cardiol. 1993;14:194-195.